Perspectives
Drug Pipeline Quarterly Update: September 2021
Drugs in review, drugs with expiring patents, generic availability and more.
September 30, 2021These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.
Related news
Perspectives
January 24, 2023
Traditional Drug Pipeline Update: January 2023
This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…
Perspectives
January 24, 2023
Specialty Pipeline Monthly Update: January 2023
This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
Perspectives
January 13, 2023
February 2023 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…